Please assess the completion status of the following clinical trial:

Trial Title: Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Willing and able to give written informed consent and comply with study requirements~* Patient who speak English~Exclusion Criteria:~* Presence or history of liver, cardiovascular, rheumatologic, cancer or renal disease.~* Current treatment with any vasodilator therapy~* Systolic blood pressure of less than 90 mmHg~* History of radial artery catheterization within the previous year~* Absence of radial artery blood flow in one or both arms~* Pregnancy.~* Active infection~* Staff members of the Cardiac Catheterization Laboratory.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Dose Test 15mg NTG (Type: EXPERIMENTAL): Nitroglycerin 15mg (NTG) applied topically to one wrist and placebo to the other wrist at Visit 1
- Dose Test 30mg NTG (Type: EXPERIMENTAL): Nitroglycerin 30mg applied topically to one wrist and placebo to the other wrist at Visit 1
- Combination Test 20mg Lidocaine (Type: EXPERIMENTAL): Lidocaine 20mg + Nitroglycerin 30mg applied topically to one wrist, Lidocaine 20mg + placebo applied to the other wrist, at Visit 2
- Combination Test 40mg Lidocaine (Type: EXPERIMENTAL): Lidocaine 40mg + Nitroglycerin 30mg applied topically to one wrist, Lidocaine 40mg + placebo applied to the other wrist, at Visit 2

Based on this trial design, predict the completion outcome and termination type (if applicable).